Portfolio (Quarterly)
Guide ↗
Vivo Capital, LLC
· CIK 0001674712| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ERAS | Erasca Inc | Healthcare | 12,151,480.0 | $196.6M | 16.34% | NEW | — | $16.18 | -22.9% |
| 2 | — | Praxis Precision Medicines | — | 338,895.0 | $109.2M | 9.08% | NEW | — | $322.19 | — |
| 3 | TERN | Terns Pharmaceuticals Inc | Healthcare | 1,334,418.0 | $70.4M | 5.85% | NEW | — | $52.72 | +0.4% |
| 4 | TRVI | Trevi Therapeutics Inc | Healthcare | 5,094,668.0 | $60.8M | 5.05% | NEW | — | $11.93 | +21.1% |
| 5 | — | DBV Technologies SA | — | 2,667,569.0 | $55.7M | 4.63% | NEW | — | $20.89 | — |
| 6 | CMPX | Compass Therapeutics Inc | Healthcare | 9,545,466.0 | $50.5M | 4.20% | NEW | — | $5.29 | -57.1% |
| 7 | TNGX | Tango Therapeutics Inc | Healthcare | 2,154,780.0 | $45.1M | 3.75% | NEW | — | $20.92 | -6.1% |
| 8 | — | SAB Biotherapeutics Inc | — | 11,420,000.0 | $43.7M | 3.64% | NEW | — | $3.83 | — |
| 9 | CRVS | Corvus Pharmaceuticals Holdings | Healthcare | 2,805,816.0 | $41.0M | 3.41% | NEW | — | $14.63 | -11.6% |
| 10 | — | Bright Minds Biosciences Inc | — | 557,172.0 | $40.7M | 3.38% | NEW | — | $72.97 | — |
| 11 | — | Sinovac Biotech Ltd. | — | 5,903,000.0 | $38.2M | 3.17% | NEW | — | $6.47 | — |
| 12 | DNTH | Dianthus Therapeutics Inc | Healthcare | 353,998.0 | $29.7M | 2.47% | NEW | — | $83.92 | +3.3% |
| 13 | DYN | Dyne Therapeutics Inc | Healthcare | 1,557,466.0 | $28.2M | 2.35% | NEW | — | $18.13 | +0.2% |
| 14 | ABVX | Abivax SA - ADR | Healthcare | 239,539.0 | $26.7M | 2.22% | NEW | — | $111.35 | +16.5% |
| 15 | NERV | Minerva Neurosciences Inc | Healthcare | 4,322,747.0 | $26.0M | 2.17% | NEW | — | $6.03 | -12.7% |
| 16 | ACRS | Aclaris Therapeutics, Inc. | Healthcare | 6,666,666.0 | $25.0M | 2.08% | NEW | — | $3.75 | +22.1% |
| 17 | ORIC | Oric Pharmaceuticals Inc | Healthcare | 1,848,786.0 | $23.4M | 1.95% | NEW | — | $12.67 | -32.3% |
| 18 | ANRO | Alto Neuroscience Inc | Healthcare | 1,035,551.0 | $23.3M | 1.94% | NEW | — | $22.48 | -9.3% |
| 19 | SNSE | Sensei Biotherapeutics Inc | Healthcare | 722,020.0 | $22.8M | 1.89% | NEW | — | $31.52 | -47.2% |
| 20 | AVBP | Arrivent BioPharma Inc | Healthcare | 885,916.0 | $20.4M | 1.70% | NEW | — | $23.07 | +19.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%